Investigation Overview
January 16, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), was announced concerning whether the takeover of NPS Pharmaceuticals, Inc. by Shire plc for $46.00 per share is unfair to NASDAQ:NPSP stockholders. The investigation by a law firm concerns whether certain officers and directors of...
You must register (for free) or login to view the entire investigation.